关键词：分子细胞遗传学；染色体；基因；功能；早期诊断
摘 要：Molecular cytogenetics is the study of chromosomes using molecular biology to understand the role and functions of genes and chromosomes. It plays a crucial role in the early diagnosis of a disease, identification of genetic tendency to cause disease, and prediction of an individual's reaction to a drug. FISH and aCGH play a prominent role in molecular cytogenetic technology. They involve screening and diagnostic tests that are used for determining the complex interaction of genes and chromosomes to assess the status of a disease. In addition, molecular cytogenetics is mainly used in research laboratories for drug discovery, identification of biomarkers, and screening drug candidates that react to the biomarkers.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Application

08. Market Segmentation by Technology

09. Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers, Acquisitions, and Partnerships

17.2 Vendor Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Abbott Laboratories

18.1.1 Key Facts

18.1.2 Business Overview

18.1.3 Business Segmentation by Revenue 2012

18.1.4 Business Segmentation by Revenue 2011and 2012

18.1.5 Sales by Geography

18.1.6 Business Strategy

18.1.7 Key Developments

18.1.8 SWOT Analysis

18.1.9 Strengths

18.1.10 Weaknesses

18.1.11 Opportunities

18.1.12 Threats

18.2 Affymetrix Inc.

18.2.1 Key Facts

18.2.2 Business Overview

18.2.3 Business Segmentation

18.2.4 Business Segmentation by Revenue 2013

18.2.5 Business Segmentation by Revenue 2012 and 2013

18.2.6 Sales by Geography

18.2.7 Business Strategy

18.2.8 Key Information

18.2.9 SWOT Analysis

18.2.10 Strengths

18.2.11 Weaknesses

18.2.12 Opportunities 9

18.2.13 Threats

18.3 Agilent Technologies Inc.

18.3.1 Key Facts

18.3.2 Business Overview

18.3.3 Business Segmentation by Revenue 2013

18.3.4 Sales by Geography

18.3.5 Business Strategy

18.3.6 Key Information

18.3.7 SWOT Analysis

18.3.8 Strengths

18.3.9 Weaknesses

18.3.10 Opportunities

18.3.11 Threats

18.4 F. Hoffmann-La Roche Ltd.

18.4.1 Key Facts

18.4.2 Business Overview

18.4.3 Business Segmentation

18.4.4 Business Strategy

18.4.5 Business Segmentation

18.4.6 Sales by Geography.

18.4.7 Key Information

18.4.8 SWOT Analysis

18.4.9 Strengths

18.4.10 Weaknesses

18.4.11 Opportunities

18.4.12 Threats

18.5 Illumina Inc.

18.5.1 Key Facts

18.5.2 Business Overview

18.5.3 Business Segmentation

18.5.4 Sales by Geography

18.5.5 Business Strategy

18.5.6 Key Information

18.5.7 SWOT Analysis

18.5.8 Strengths

18.5.9 Weaknesses

18.5.10 Opportunities

18.5.11 Threats

18.6 PerkinElmer Inc.

18.6.1 Key Facts

18.6.2 Business Overview

18.6.3 Business Segmentation

18.6.4 Business Strategy

18.6.5 Business Segmentation by Revenue

18.6.6 Key Developments

18.6.7 SWOT Analysis

18.6.8 Strengths

18.6.9 Weaknesses

18.6.10 Opportunities

18.6.11 Threats

19. Other Reports in this Series